Related Experiment Video
Updated: Feb 12, 2026

Glycomics-Guided Glycoproteomics Facilitates Comprehensive Profiling of the Glycoproteome in Complex Tumor Microenvironments
Published on: February 7, 2025
Anti-miRNA oligonucleotides: A comprehensive guide for design
Joana Filipa Lima1,2,3,4, Laura Cerqueira1,2, Ceu Figueiredo3,4,5
1a LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Department of Chemical Engineering , Faculty of Engineering of the University of Porto , R. Dr. Roberto Frias, Porto , Portugal.
Aberrant microRNAs (miRNAs) drive disease, but antisense oligonucleotides (AMOs) offer therapeutic potential. Advanced AMO designs enhance efficacy for novel miRNA-based treatments and diagnostics.
Area of Science:
- Molecular Biology
- Genetics
- Biochemistry
Background:
- MicroRNAs (miRNAs) are small, non-coding RNAs regulating gene expression post-transcriptionally.
- Aberrant miRNA expression is implicated in the pathogenesis of numerous human diseases.
- This implicates miRNAs as crucial targets for novel therapeutic strategies.
Purpose of the Study:
- To review technologies for suppressing aberrant microRNAs (miRNAs).
- To discuss antisense oligonucleotide (AMO) design strategies for improved potency and nuclease resistance.
- To explore AMO applications in miRNA-based therapeutics and detection.
Main Methods:
- Review of scientific literature on miRNA regulation and therapeutic strategies.
- Analysis of antisense oligonucleotide (AMO) design principles and chemical modifications.
- Examination of current and emerging applications of AMOs in disease treatment and diagnostics.
Main Results:
- Antisense oligonucleotides (AMOs), particularly chemically modified ones like locked nucleic acid oligonucleotides, show significant promise in silencing aberrant miRNAs.
- Optimized AMO design can enhance nuclease resistance and target affinity, improving therapeutic efficacy.
- AMOs are being developed for novel miRNA-based therapeutics and sensitive detection methodologies.
Conclusions:
- Aberrant microRNAs (miRNAs) are key players in human disease pathogenesis.
- Antisense oligonucleotides (AMOs) represent a viable therapeutic approach for controlling aberrant miRNAs.
- Advanced AMO design and application are crucial for developing effective miRNA-based diagnostics and treatments.
Related Concept Videos
Group Design
Factorial Design
Design Example: Designing a Residential Plumbing System
Design Example: Designing Water Slide
Bernoulli's principle determines the water's velocity along the slide....
Design Example: Design of an Irrigation Channel
Design Example

